Eternal's valuation has now surpassed the market capitalisation of several established names, including Wipro ( ₹2.72 lakh crore), Tata Motors ( ₹2.52 lakh crore), Coal India ( ₹2.40 lakh crore), ...

Biocon Biologics, a subsidiary of Biocon, has launched Nepexto, a biosimilar to Enbrel, in Australia. Nepexto is indicated for the treatment of autoimmune conditions like rheumatoid arthritis and ...